Literature DB >> 19795462

Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis.

Nikolas H Stoecklein1, Christoph A Klein.   

Abstract

Recent genetic analyses of paired samples from primary tumours and disseminated tumour cells have uncovered a bewildering genetic disparity. It was therefore proposed that ectopically residing tumour cells disseminate early and develop independently into metastases parallel to the primary tumour. Alternatively, these cells may represent an irrelevant cell population unable to spawn metastases whereas only cells that disseminated late in primary tumour development (which therefore are similar to the primary tumour) will form manifest metastasis. Here, we review comparative analyses of paired samples from primary tumours and disseminated tumour cells or primary tumours and metastases. The data demonstrate a striking disparity, questioning the use of primary tumours as surrogate for the genetics of systemic cancer. In the era of molecular therapies that build upon genetic defects of tumour cells, these data call for a direct diagnostic pathology of systemic cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19795462     DOI: 10.1002/ijc.24916

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  74 in total

Review 1.  Biology and significance of circulating and disseminated tumour cells in colorectal cancer.

Authors:  Gunnar Steinert; Sebastian Schölch; Moritz Koch; Jürgen Weitz
Journal:  Langenbecks Arch Surg       Date:  2012-02-15       Impact factor: 3.445

Review 2.  The lymphatic vasculature in disease.

Authors:  Kari Alitalo
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

3.  Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology.

Authors:  George Somlo; Sean K Lau; Paul Frankel; H Ben Hsieh; Xiaohe Liu; Lixin Yang; Robert Krivacic; Richard H Bruce
Journal:  Breast Cancer Res Treat       Date:  2011-04-16       Impact factor: 4.872

4.  Biological resonance for cancer metastasis, a new hypothesis based on comparisons between primary cancers and metastases.

Authors:  Dongwei Gao; Sha Li
Journal:  Cancer Microenviron       Date:  2013-11-10

5.  Selection and adaptation during metastatic cancer progression.

Authors:  Christoph A Klein
Journal:  Nature       Date:  2013-09-19       Impact factor: 49.962

Review 6.  Intratumoral heterogeneity: Clonal cooperation in epithelial-to-mesenchymal transition and metastasis.

Authors:  Deepika Neelakantan; David J Drasin; Heide L Ford
Journal:  Cell Adh Migr       Date:  2014-10-16       Impact factor: 3.405

7.  Prognostic Relevance of Circulating Tumor Cells in Molecular Subtypes of Breast Cancer.

Authors:  M Banys-Paluchowski; H Schneck; C Blassl; S Schultz; F Meier-Stiegen; D Niederacher; N Krawczyk; E Ruckhaeberle; T Fehm; H Neubauer
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-03       Impact factor: 2.915

8.  Molecular Markers as Prognostic Factors in DCIS and Small Invasive Breast Cancers.

Authors:  N Sänger; K Engels; A Graf; E Ruckhäberle; K E Effenberger; T Fehm; U Holtrich; S Becker; T Karn
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-11       Impact factor: 2.915

Review 9.  Pancreatic cancer: Are "liquid biopsies" ready for prime-time?

Authors:  Alexandra R Lewis; Juan W Valle; Mairead G McNamara
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

10.  Single-cell genetic analysis of ductal carcinoma in situ and invasive breast cancer reveals enormous tumor heterogeneity yet conserved genomic imbalances and gain of MYC during progression.

Authors:  Kerstin Heselmeyer-Haddad; Lissa Y Berroa Garcia; Amanda Bradley; Clarymar Ortiz-Melendez; Woei-Jyh Lee; Rebecca Christensen; Sheila A Prindiville; Kathleen A Calzone; Peter W Soballe; Yue Hu; Salim A Chowdhury; Russell Schwartz; Alejandro A Schäffer; Thomas Ried
Journal:  Am J Pathol       Date:  2012-10-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.